Views: 0 Author: Site Editor Publish Time: 2023-05-24 Origin: Site
One reason many of us work in health care is the sense of pride we feel about continual discovery and our own roles in making these innovations accessible to patients and providing ongoing educational support.
For diabetes, which affects 37 million Americans,1 there have been important strides, yet an alarming number of people living with this chronic condition do not meet their glycemic targets. This is due, in large part, to the fact that for many, the resources needed for everyday disease self-management are out of reach. As a result, the economic and clinical burden gets deeper and harder to solve every year.
Pharmacies have long embraced innovation and technology, with early adoption of telehealth and digital platforms. At my company, we are committed to innovation as well and make significant investments in AI, digital solutions, and product development, all with the goal of improving everyday disease management for people with diabetes, their families, and their health care teams.
What’s endlessly fascinating about innovation is that it presents in many forms and is sometimes in plain sight. Indeed, the most forward-thinking solution is sometimes the longest-standing.
It turns out that blood glucose monitoring, widely available both in the pharmacy and on retail shelves, not only revolutionized the treatment of diabetes 40 years ago,2 but continues to be the innovation that improves outcomes and also addresses the elephants in the room: access and affordability.
